Name: YDES Income Statement - Yd Bio Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

YDES - Yd Bio Ltd.

USD | NASDAQ | Healthcare

YDES Income Statement - Yd Bio Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	FY2025	FY2024	FY2023
Revenues
Revenues	0.6	0.5	0.4
Cost of Revenue	0.4	0.4	0.2
Gross Profit	0.2	0.2	0.2
Operating Expenses
Research & Development	1.6	0.5	-
Selling General & Administrative	-	-	-
Selling & Marketing	0.2	0.0	0.0
General & Administrative
Operating Income
Operating Income	(5.3)	(1.5)	(0.0)
Non-Operating
Interest Income	0.1	0.0	0.0
Interest Expense	-	0.0	0.0
Income From Equity Investments	-	-	-
Other Non-Operating Income
Tax & Net
Income Tax Expense	(0.0)	0.0	0.0
Net Income From Continuing Ops	(8.3)	(1.4)	0.0
Net Income From Discontinued Ops	-	-	-
Net Income
Per Share
EPS Basic	(0.12)	(0.02)	0.00
EPS Diluted	(0.12)	(0.02)	0.00
Shares Basic	66.7	64.7	64.7
Shares Diluted	66.7
Supplementary Data
EBITDA	(5.3)	(1.5)	(0.0)
EBIT	(5.3)	(1.5)	(0.0)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)